Renalytix PLC
LSE:RENX
EV/GP
Enterprise Value to Gross Profit
Market Cap | EV/GP | ||||
---|---|---|---|---|---|
UK |
Renalytix PLC
LSE:RENX
|
29m GBP | -2 621.2 | ||
US |
Veeva Systems Inc
NYSE:VEEV
|
34.1B USD | 17.8 | ||
US |
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 6 | ||
US |
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 6.4 | ||
AU |
Pro Medicus Ltd
ASX:PME
|
12.5B AUD | 82.6 | ||
JP |
M3 Inc
TSE:2413
|
1.1T JPY | 6.8 | ||
US |
Inspire Medical Systems Inc
NYSE:INSP
|
4.7B USD | 7.7 | ||
US |
Doximity Inc
NYSE:DOCS
|
4.4B USD | 9 | ||
SE |
Sectra AB
STO:SECT B
|
45.5B SEK | 58.7 | ||
US |
Vocera Communications Inc
NYSE:VCRA
|
2.8B USD | 17 | ||
US |
Goodrx Holdings Inc
NASDAQ:GDRX
|
2.7B USD | 4 |
EV/GP Forward Multiples
Forward EV/GP multiple is a version of the EV/GP ratio that uses forecasted gross profit for the EV/GP calculation. 1-Year, 2-Years, and 3-Years forwards use gross profit forecasts for 1, 2, and 3 years ahead, respectively.